Vectus Biosystems Ltd (VBS) - Net Assets

Latest as of June 2025: AU$-256.62K AUD ≈ $-181.58K USD

Based on the latest financial reports, Vectus Biosystems Ltd (VBS) has net assets worth AU$-256.62K AUD (≈ $-181.58K USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$782.66K ≈ $553.78K USD) and total liabilities (AU$1.04 Million ≈ $735.36K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check VBS asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	AU$-256.62K
% of Total Assets	-32.79%
Annual Growth Rate	N/A
5-Year Change	N/A
10-Year Change	-106.85%
Growth Volatility	7209.56

Vectus Biosystems Ltd - Net Assets Trend (2012–2025)

This chart illustrates how Vectus Biosystems Ltd's net assets have evolved over time, based on quarterly financial data. Also explore Vectus Biosystems Ltd (VBS) total assets for the complete picture of this company's asset base.

Annual Net Assets for Vectus Biosystems Ltd (2012–2025)

The table below shows the annual net assets of Vectus Biosystems Ltd from 2012 to 2025. For live valuation and market cap data, see Vectus Biosystems Ltd stock valuation.

Year	Net Assets	Change
2025-06-30	AU$-256.62K ≈ $-181.58K	-117.27%
2024-06-30	AU$1.49 Million ≈ $1.05 Million	-57.82%
2023-06-30	AU$3.52 Million ≈ $2.49 Million	+179.69%
2022-06-30	AU$-4.42 Million ≈ $-3.13 Million	-52.50%
2021-06-30	AU$-2.90 Million ≈ $-2.05 Million	+56.79%
2020-06-30	AU$-6.71 Million ≈ $-4.75 Million	-79.91%
2019-06-30	AU$-3.73 Million ≈ $-2.64 Million	-65.30%
2018-06-30	AU$-2.26 Million ≈ $-1.60 Million	-2035.78%
2017-06-30	AU$116.56K ≈ $82.48K	-96.89%
2016-06-30	AU$3.75 Million ≈ $2.65 Million	-66.58%
2015-06-30	AU$11.22 Million ≈ $7.94 Million	+20101.70%
2014-06-30	AU$55.53K ≈ $39.29K	-94.31%
2013-06-30	AU$976.04K ≈ $690.61K	+293.44%
2012-06-30	AU$-504.57K ≈ $-357.02K	--

Equity Component Analysis

This analysis shows how different components contribute to Vectus Biosystems Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 3322142600.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (June 2025)

Component	Amount	Percentage
Common Stock	AU$38.37 Million	%
Other Comprehensive Income	AU$878.10K	%
Other Components	AU$1.00	%
Total Equity	AU$-256.62K	100.00%

Vectus Biosystems Ltd Competitors by Market Cap

The table below lists competitors of Vectus Biosystems Ltd ranked by their market capitalization.

Company	Market Cap
IDeA Indonesia Akademi Tbk PT JK:IDEA	$4.73 Million
Neolife SA PA:ALNLF	$4.73 Million
Tourn International AB ST:TOURN	$4.73 Million
Qualigen Therapeutics Inc NASDAQ:QLGN	$4.74 Million
DEFSEC Technologies Inc. NASDAQ:DFSC	$4.72 Million
Cluey Ltd AU:CLU	$4.72 Million
amalphi ag F:AMI	$4.72 Million
PT Trimuda Nuansa Citra Tbk JK:TNCA	$4.72 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Vectus Biosystems Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 1,486,365 to -256,622, a change of -1,742,987 (-117.3%).
Net loss of 1,777,259 reduced equity.
Other comprehensive income increased equity by 34,272.
Other factors decreased equity by 0.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	AU$-1.78 Million	-692.56%
Other Comprehensive Income	AU$34.27K	+13.36%
Total Change	AU$-	-117.27%

Book Value vs Market Value Analysis

This analysis compares Vectus Biosystems Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2012-06-30	AU$-0.03	AU$0.13	x
2013-06-30	AU$0.06	AU$0.13	x
2014-06-30	AU$0.00	AU$0.13	x
2015-06-30	AU$0.79	AU$0.13	x
2016-06-30	AU$0.18	AU$0.13	x
2017-06-30	AU$0.00	AU$0.13	x
2018-06-30	AU$-0.10	AU$0.13	x
2019-06-30	AU$-0.16	AU$0.13	x
2020-06-30	AU$-0.29	AU$0.13	x
2021-06-30	AU$-0.10	AU$0.13	x
2022-06-30	AU$-0.13	AU$0.13	x
2023-06-30	AU$0.07	AU$0.13	x
2024-06-30	AU$0.03	AU$0.13	x
2025-06-30	AU$0.00	AU$0.13	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Vectus Biosystems Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 0.00%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -371.67%
• Asset Turnover: 0.61x
• Equity Multiplier: 0.00x
Recent ROE (0.00%) is above the historical average (-457.61%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2012	0.00%	0.00%	0.00x	0.00x	AU$-1.38 Million
2013	-126.83%	-187.64%	0.44x	1.53x	AU$-1.34 Million
2014	-2669.02%	-169.92%	1.21x	12.93x	AU$-1.49 Million
2015	-14.76%	-56111.49%	0.00x	1.05x	AU$-2.78 Million
2016	-85.65%	-4277.57%	0.02x	1.25x	AU$-3.59 Million
2017	-3255.11%	-7690.48%	0.07x	6.18x	AU$-3.81 Million
2018	0.00%	-141614.45%	0.01x	0.00x	AU$-2.36 Million
2019	0.00%	-725581.82%	0.00x	0.00x	AU$-1.22 Million
2020	0.00%	-5853.30%	0.02x	0.00x	AU$-2.33 Million
2021	0.00%	-2145135.56%	0.00x	0.00x	AU$-3.57 Million
2022	0.00%	-307.19%	0.33x	0.00x	AU$-3.55 Million
2023	-97.88%	-254.62%	0.29x	1.31x	AU$-3.80 Million
2024	-157.30%	-205.34%	0.56x	1.36x	AU$-2.49 Million
2025	0.00%	-371.67%	0.61x	0.00x	AU$-1.75 Million

Industry Comparison

This section compares Vectus Biosystems Ltd's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $9,810,720
Average return on equity (ROE) among peers: -71.07%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Vectus Biosystems Ltd (VBS)	AU$-256.62K	0.00%	N/A	$4.73 Million
Adalta Ltd (1AD)	$3.70 Million	-162.25%	0.87x	$6.50 Million
Algorae Pharmaceuticals Ltd (1AI)	$-1.33 Million	0.00%	0.00x	$20.04 Million
ACRUX Ltd (ACR)	$12.85 Million	-73.71%	0.44x	$3.20 Million
Actinogen Medical Ltd (ACW)	$21.74 Million	-43.69%	0.07x	$105.70 Million
Argenica Therapeutics Ltd (AGN)	$13.95 Million	-39.28%	0.17x	$15.45 Million
Arovella Therapeutics Ltd (ALA)	$11.03 Million	-40.87%	0.23x	$58.08 Million
Anatara Lifesciences Ltd (ANR)	$924.54K	-218.83%	0.54x	$1.57 Million
Alterity Therapeutics Ltd (ATH)	$20.73 Million	-6.40%	0.01x	$76.95 Million
Amplia Therapeutics Ltd (ATX)	$11.23 Million	-30.16%	0.02x	$50.82 Million
Avecho Biotechnology Ltd (AVE)	$3.27 Million	-95.48%	0.53x	$28.59 Million

About Vectus Biosystems Ltd

AU:VBS Australia Biotechnology

Market Cap

$4.73 Million

AU$6.68 Million AUD

Market Cap Rank

#28452 Global

#1581 in Australia

Share Price

AU$0.13

Change (1 day)

+13.64%

52-Week Range

AU$0.04 - AU$0.44

All Time High

AU$2.00